NLRP3 and diabetes mellitus: The increased ligand-receptor binding was accompanied by significantly elevated levels of the NLRP3 inflammasome in HFpEF patients with DM compared to their non-diabetic counterparts (Fig. 1G), although no significant differences were noted in NLRP3 and NFκB protein expression levels between the two groups (Fig. 1F, H).